{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:26:11Z","timestamp":1794565571950,"version":"4.9.1"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119011","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:25:02Z","timestamp":1780118702000},"page":"119011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dengue virus nonstructural proteins as small-molecule targets: Advances, challenges, and future directions"],"prefix":"10.1016","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9004-4514","authenticated-orcid":false,"given":"Vrajesh B.","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasinath","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sachchidanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul R.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit C.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119011_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119011_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0065-3527(03)59009-1","article-title":"Microevolution and virulence of dengue viruses","volume":"59","author":"Rico-Hesse","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ejmech.2026.119011_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijid.2021.07.062","article-title":"Risk factors for hospitalization and mortality due to dengue fever in a Mexican population: a retrospective cohort study","volume":"110","author":"Fonseca-Portilla","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/v17020212","article-title":"Current Dengue virus vaccine developments and future directions","volume":"17","author":"Anumanthan","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119011_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116069","article-title":"Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses","volume":"265","author":"He","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib7","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20240134","article-title":"Dengue virus: pathogenesis and potential for small molecule inhibitors","volume":"44","author":"Chauhan","year":"2024","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2026.119011_bib8","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3390\/v16111724","article-title":"Effectiveness of direct antiviral agents in people with HCV-Monoinfection compared to HCV\/HIV coinfection in a real life setting","volume":"16","author":"Rom\u00e1n L\u00f3pez","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119011_bib9","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1021\/acs.jmedchem.5b01653","article-title":"The medicinal chemistry of Dengue virus","volume":"59","author":"Behnam","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib10","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.2174\/0929867326666181204155336","article-title":"Discovery of Dengue virus inhibitors","volume":"27","author":"Abdullah","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1039\/D0MD00052C","article-title":"Recent progress on phenotype-based discovery of dengue inhibitors","volume":"11","author":"Yokokawa","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113527","article-title":"Dengue structural proteins as antiviral drug targets: current status in the drug discovery & development","volume":"221","author":"S","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101305","article-title":"Flavivirus nonstructural proteins and replication complexes as antiviral drug targets","volume":"59","author":"van den Elsen","year":"2023","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2026.119011_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/acsmedchemlett.1c00617","article-title":"Antivirals against (re)emerging flaviviruses: should we target the virus or the host?","volume":"13","author":"P\u00e9rez-P\u00e9rez","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119011_bib15","first-page":"217","article-title":"Genomics, proteomics and evolution of dengue virus","volume":"16","author":"Dwivedi","year":"2017","journal-title":"Brief. Funct. Genom."},{"key":"10.1016\/j.ejmech.2026.119011_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/membranes12020231","article-title":"Structures and dynamics of Dengue virus nonstructural membrane proteins","volume":"12","author":"Li","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.ejmech.2026.119011_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/acsinfecdis.3c00566","article-title":"Roles of NS1 protein in Flavivirus pathogenesis","volume":"10","author":"Perera","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcp.2018.04.008","article-title":"Dengue virus NS2 and NS4: minor proteins, mammoth roles","volume":"154","author":"Gopala Reddy","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119011_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12250-014-3438-6","article-title":"Functional interplay among the flavivirus NS3 protease, helicase, and cofactors","volume":"29","author":"Li","year":"2014","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ejmech.2026.119011_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12551-023-01101-5","article-title":"Thermodynamic and mechanistic analysis of the functional properties of dengue virus NS3 helicase","volume":"15","author":"Incicco","year":"2023","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ejmech.2026.119011_bib21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/v13102077","article-title":"Roles of non-structural protein 4A in Flavivirus infection","volume":"13","author":"Klaitong","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119011_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105423","article-title":"Flavivirus NS4B protein: structure, function, and antiviral discovery","volume":"207","author":"Wang","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119011_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/vaccines12080865","article-title":"The flavivirus non-structural protein 5 (NS5): structure, functions, and targeting for development of vaccines and therapeutics","volume":"12","author":"Goh","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ejmech.2026.119011_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","article-title":"Dengue drug discovery: progress, challenges and outlook","volume":"163","author":"Lim","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119011_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2404159","article-title":"Progress and challenges in development of animal models for dengue virus infection","volume":"13","author":"Yuya","year":"2024","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2026.119011_bib26","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1007\/s11030-025-11131-8","article-title":"Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents","volume":"29","author":"Almulhim","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.119011_bib27","article-title":"Repurposing FDA-approved drugs and natural compounds to inhibit the RNA-dependent RNA polymerase domain of dengue virus 2 or dengue virus 3","volume":"15","author":"Ahmadi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119011_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12929-024-01116-4","article-title":"A non-structural protein 1 substitution of dengue virus enhances viral replication by interfering with the antiviral signaling pathway","volume":"32","author":"Hee","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejmech.2026.119011_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105330","article-title":"Sulfated \u03b2-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis","volume":"203","author":"Sousa","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119011_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107914","article-title":"Advances in drug discovery of flavivirus NS2B-NS3pro serine protease inhibitors for the treatment of Dengue, Zika, and West Nile viruses","volume":"153","author":"Jo\u00e3o","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib31","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/molecules29174047","article-title":"Orthoflaviviral inhibitors in clinical trials, preclinical in vivo efficacy targeting NS2B-NS3 and cellular antiviral activity via competitive protease inhibition","volume":"29","author":"Cavina","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119011_bib32","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1021\/acs.jmedchem.9b01697","article-title":"Proline-Based allosteric inhibitors of zika and Dengue virus NS2B\/NS3 proteases","volume":"62","author":"Millies","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116392","article-title":"SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B\/NS3 proteases","volume":"47","author":"Maus","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib34","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jacs.9b02505","article-title":"Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of Flavivirus NS2B-NS3 protease","volume":"141","author":"Yao","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119011_bib35","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1021\/acs.jmedchem.0c02070","article-title":"Synthesis, structure-activity relationships, and antiviral activity of allosteric inhibitors of Flavivirus NS2B-NS3 protease","volume":"64","author":"Nie","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113767","article-title":"Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease","volume":"225","author":"Nie","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113695","article-title":"Amidoxime prodrugs convert to potent cell-active multimodal inhibitors of the dengue virus protease","volume":"224","author":"Swarbrick","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejmech.2019.07.007","article-title":"Cell-active carbazole derivatives as inhibitors of the zika virus protease","volume":"180","author":"Rassias","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116213","article-title":"Carbazole to indolazepinone scaffold morphing leads to potent cell-active dengue antivirals","volume":"268","author":"Zogali","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib40","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1021\/acs.jmedchem.0c00413","article-title":"A new class of Dengue and West Nile Virus protease inhibitors with submicromolar activity in reporter gene DENV-2 protease and viral replication assays","volume":"63","author":"K\u00fchl","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib41","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1021\/acs.jmedchem.0c02042","article-title":"Beyond basicity: discovery of nonbasic DENV-2 protease inhibitors with potent activity in cell culture","volume":"64","author":"K\u00fchl","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114585","article-title":"Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases","volume":"240","author":"K\u00fchl","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib43","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.2147\/DDDT.S94207","article-title":"Identification of covalent active site inhibitors of dengue virus protease","volume":"9","author":"Koh-Stenta","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.119011_bib44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbrc.2022.08.060","article-title":"Discovery of highly potent DENV NS2B-NS3 covalent inhibitors containing a phenoxymethylphenyl residue","volume":"627","author":"Cheng","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.119011_bib45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/acsmedchemlett.1c00653","article-title":"Identification and in silico binding Study of a highly potent DENV NS2B-NS3 covalent inhibitor","volume":"13","author":"Lin","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119011_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01258-23","article-title":"Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection","volume":"98","author":"Huang","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119011_bib47","article-title":"Flavivirus inhibitors","author":"Ontoria Ontoria","year":"2025","journal-title":"WO patent WO2025114399A1, June 5"},{"key":"10.1016\/j.ejmech.2026.119011_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106408","article-title":"Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses","volume":"133","author":"Del Rosario Garc\u00eda-Lozano","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2018.05.003","article-title":"Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A","volume":"55","author":"Nobori","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119011_bib50","article-title":"Dengue virus NS4B protein as a target for developing antivirals","volume":"12","author":"Li","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119011_bib51","series-title":"Spiropyrazolopyridine Derivatives and Uses Thereof for the Treatment of Viral Infections","author":"Chan","year":"2014"},{"key":"10.1016\/j.ejmech.2026.119011_bib52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/ml500521r","article-title":"Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors","volume":"6","author":"Zou","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119011_bib53","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1128\/JVI.00855-15","article-title":"Discovery of Dengue virus NS4B inhibitors","volume":"89","author":"Wang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119011_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127162","article-title":"Design, synthesis and biological evaluation of spiropyrazolopyridone derivatives as potent dengue virus inhibitors","volume":"30","author":"Xu","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119011_bib55","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1021\/acs.jmedchem.9b00698","article-title":"Design, synthesis, and biological evaluation of substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues as potent NS4B inhibitors for the treatment of Dengue virus infection","volume":"62","author":"Xu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib56","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1128\/JVI.05468-11","article-title":"Inhibition of dengue virus by targeting viral NS4B protein","volume":"85","author":"Xie","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119011_bib57","article-title":"N-substituted tetrahydrothienopyridine derivatives uses thereof","author":"Kounde","year":"2019","journal-title":"WO patent WO2019244047A1, Dec 26"},{"key":"10.1016\/j.ejmech.2026.119011_bib58","doi-asserted-by":"crossref","first-page":"eabb2181","DOI":"10.1126\/scitranslmed.abb2181","article-title":"NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models","volume":"13","author":"Moquin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119011_bib59","article-title":"Mechanistic insights into dengue virus inhibition by a clinical trial compound NITD-688","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.119011_bib60","series-title":"Viral Replication Inhibitors, WO Patent WO2013045516A1, Apr 4","author":"Bardiot","year":"2013"},{"key":"10.1016\/j.ejmech.2026.119011_bib61","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.1021\/acs.jmedchem.8b00913","article-title":"Discovery of indole derivatives as novel and potent Dengue virus inhibitors","volume":"61","author":"Bardiot","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib62","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1021\/acs.jmedchem.3c00403","article-title":"Discovery of acyl-indole derivatives as pan-serotype Dengue virus NS4B inhibitors","volume":"66","author":"Kesteleyn","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib63","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/acs.jmedchem.3c02336","article-title":"Discovery of JNJ-1802, a first-in-class pan-serotype Dengue Virus NS4B inhibitor","volume":"67","author":"Kesteleyn","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib64","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119011_bib65","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1038\/s41467-024-52819-z","article-title":"Genomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir","volume":"15","author":"Bouzidi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119011_bib66","article-title":"2-(4-chloro-2 methoxyphenyl)-2-((3-methoxy-5-(methylsulfonyl)phenyl)amino)-l-(5-(trifluoromethoxy)-lH-indol-3-yl)ethan-l-one and pharmaceutical compositions comprising the same","author":"Christos","year":"2026","journal-title":"WO patent WO2026018176A1, Jan 22"},{"key":"10.1016\/j.ejmech.2026.119011_bib67","series-title":"Substituted Indoline Derivatives as Dengue Viral Replication Inhibitors","author":"Kesteleyn","year":"2017"},{"key":"10.1016\/j.ejmech.2026.119011_bib68","series-title":"WO Patent WO2018215316A1, Nov 29","author":"Bonfanti","year":"2018"},{"key":"10.1016\/j.ejmech.2026.119011_bib69","series-title":"WO Patent WO2018178240A1, Oct 4","author":"Kesteleyn","year":"2018"},{"key":"10.1016\/j.ejmech.2026.119011_bib70","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","article-title":"A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction","volume":"598","author":"Kaptein","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119011_bib71","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41467-024-50437-3","article-title":"Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B\/NS3 and blocks replication organelle formation","volume":"15","author":"Kiemel","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119011_bib72","doi-asserted-by":"crossref","first-page":"eadr8338","DOI":"10.1126\/sciadv.adr8338","article-title":"The antiviral JNJ-A07 significantly reduces dengue virus transmission by Aedes aegypti mosquitoes when delivered via blood-feeding","volume":"10","author":"Rosales-Rosas","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119011_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115416","article-title":"Perspectives on the current antiviral developments towards RNA-dependent RNA polymerase (RdRp) and methyltransferase (MTase) domains of dengue virus non-structural protein 5 (DENV-NS5)","volume":"256","author":"Sreekanth","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib74","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.2174\/1381612826666200523174753","article-title":"A review on the progress and prospects of Dengue drug discovery targeting NS5 RNA-Dependent RNA polymerase","volume":"26","author":"Maddipati","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2026.119011_bib75","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/acschembio.5b00781","article-title":"Structural chemistry of human RNA methyltransferases","volume":"11","author":"Schapira","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119011_bib76","doi-asserted-by":"crossref","first-page":"16212","DOI":"10.1021\/jacs.6b10399","article-title":"Structural Insight into NS5 of zika virus leading to the discovery of MTase inhibitors","volume":"138","author":"Stephen","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119011_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115290","article-title":"Recent advances in the development of methyltransferase (MTase) inhibitors against (re)emerging arboviruses diseases dengue and Zika","volume":"252","author":"Delgado-Maldonado","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131756","article-title":"RdRp (RNA-dependent RNA polymerase): a key target providing anti-virals for the management of various viral diseases","volume":"1250","author":"Pathania","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119011_bib79","doi-asserted-by":"crossref","first-page":"18752","DOI":"10.1021\/acs.jmedchem.5c00709","article-title":"Assessing the design of pyrimidine-based nucleoside analogs targeting dengue and zika RNA-Dependent RNA polymerase: what are the rules?","volume":"68","author":"Sethiya","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib80","article-title":"Dosage regimens for treatment of dengue infection","author":"Moussa","year":"2023","journal-title":"WO patent WO2023230348A2, Nov 30"},{"key":"10.1016\/j.ejmech.2026.119011_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00988-21","article-title":"Evaluation of AT-752, a double prodrug of a guanosine nucleotide analog with in vitro and in vivo activity against Dengue and other flaviviruses","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119011_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105574","article-title":"AT-752 targets multiple sites and activities on the Dengue virus replication enzyme NS5","volume":"212","author":"Feracci","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119011_bib83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/acsbiomedchemau.4c00071","article-title":"Synthesis and modification of cordycepin-phosphoramidate ProTide derivatives for antiviral activity and metabolic stability","volume":"5","author":"Thiraporn","year":"2025","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.ejmech.2026.119011_bib84","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.3390\/molecules26113118","article-title":"Cordycepin inhibits virus replication in Dengue virus-infected vero cells","volume":"26","author":"Panya","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119011_bib85","article-title":"4\u2019-Substituted nucleosides and nucleotides as antiviral agents","author":"Chatterjee","year":"2024","journal-title":"WO patent WO2024227159, Oct 31"},{"key":"10.1016\/j.ejmech.2026.119011_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03097-22","article-title":"Small-Molecule inhibitor of flaviviral NS3-NS5 interaction with broad-spectrum activity and efficacy in vivo","volume":"14","author":"Celegato","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119011_bib87","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.antiviral.2016.09.007","article-title":"Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor","volume":"134","author":"Tarantino","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119011_bib88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/acsmedchemlett.9b00619","article-title":"Pyridobenzothiazolones exert potent anti-dengue activity by hampering multiple functions of NS5 polymerase","volume":"11","author":"Cannalire","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119011_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500163","article-title":"New pyridobenothiazolone derivatives display Nanomolar pan-serotype anti-dengue virus activity","volume":"20","author":"Felicetti","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119011_bib90","doi-asserted-by":"crossref","first-page":"10746","DOI":"10.1021\/acs.jmedchem.3c00924","article-title":"Quinazolinone compounds have potent antiviral activity against zika and Dengue virus","volume":"66","author":"Ashraf-Uz-Zaman","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119011_bib91","article-title":"Substituted Tetrahydrobenzothiophene and Tetrahydropyridothiophene derivatives as potential antiviral agents","author":"Moukha-Chafiq","year":"2025","journal-title":"WO patent WO2025175175A1, Aug 21"},{"key":"10.1016\/j.ejmech.2026.119011_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib93","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib94","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/civ949","article-title":"Lovastatin for the treatment of adult patients with dengue: a randomized, Double-Blind, placebo-controlled trial","volume":"62","author":"Whitehorn","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004851","article-title":"Extended evaluation of virological, immunological and pharmacokinetic endpoints of CELADEN: a randomized, placebo-controlled trial of Celgosivir in Dengue fever patients","volume":"10","author":"Sung","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib96","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00705-020-04524-7","article-title":"The small molecule AZD6244 inhibits dengue virus replication in vitro and protects against lethal challenge in a mouse model","volume":"165","author":"de Oliveira","year":"2020","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejmech.2026.119011_bib97","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/v14061228","article-title":"Azelnidipine exhibits in vitro and in vivo antiviral effects against flavivirus infections by targeting the viral RdRp","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119011_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118104","article-title":"Drug repositioning: identification of potent inhibitors of NS3 protease and NS5 RdRp for control of DENV infection","volume":"187","author":"Rashid","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119011_bib99","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/acsinfecdis.0c00052","article-title":"Broad spectrum antiviral agent Niclosamide and its therapeutic potential","volume":"6","author":"Xu","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib100","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2026.119011_bib101","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1038\/s41598-019-45095-1","article-title":"Neutralization of acidic intracellular vesicles by Niclosamide inhibits multiple steps of the Dengue virus life cycle in vitro","volume":"9","author":"Jung","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119011_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006715","article-title":"The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR","volume":"12","author":"Kao","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib103","doi-asserted-by":"crossref","first-page":"14541","DOI":"10.1021\/acs.nanolett.4c02845","article-title":"Insight into preventing global dengue spread: nanoengineered niclosamide for viral infections","volume":"24","author":"Rejinold","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejmech.2026.119011_bib105","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1021\/acsinfecdis.0c00217","article-title":"JMX0207, a niclosamide derivative with improved pharmacokinetics, suppresses zika virus infection both in vitro and in vivo","volume":"6","author":"Li","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib106","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.119011_bib107","doi-asserted-by":"crossref","first-page":"e586","DOI":"10.1093\/cid\/ciaa1332","article-title":"Ivermectin accelerates circulating nonstructural protein 1 (NS1) clearance in adult dengue patients: a combined phase 2\/3 randomized double-blinded placebo controlled trial","volume":"72","author":"Suputtamongkol","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib108","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/psp4.13233","article-title":"In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever","volume":"13","author":"Ding","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119011_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108294","article-title":"An ivermectin - atorvastatin combination impairs nuclear transport inhibiting dengue infection in vitro and in vivo","volume":"26","author":"Palacios-R\u00e1palo","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2026.119011_bib110","article-title":"Antiviral activity of pimecrolimus against dengue virus type 2 infection in vitro and in vivo","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119011_bib111","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2004.09.096","article-title":"North American Brain Tumor Consortium, Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: a North American Brain Tumor Consortium study","volume":"22","author":"Puduvalli","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119011_bib112","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/infdis\/jiu319","article-title":"A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection","volume":"210","author":"Fraser","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/cid\/ciad284","article-title":"Safety, tolerability, and pharmacokinetics of JNJ-1802, a pan-serotype Dengue direct antiviral small molecule, in a phase 1, Double-Blind, randomized, dose-escalation Study in healthy volunteers","volume":"77","author":"Ackaert","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119011_bib116","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/cpdd.1574","article-title":"Pharmacokinetics, safety, and tolerability of different maintenance dose regimens of Mosnodenvir (JNJ-1802) in healthy adult participants","volume":"14","author":"Kakuda","year":"2025","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ejmech.2026.119011_bib117","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa2500179","article-title":"Daily Mosnodenvir as Dengue prophylaxis in a controlled human infection model","volume":"393","author":"Durbin","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119011_bib119","series-title":"Safety and Pharmacokinetics of EYU688 in Patients with Dengue Fever","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119011_bib121","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01615-23","article-title":"First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus","volume":"68","author":"Zhou","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119011_bib122","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4269\/ajtmh.24-0696","article-title":"Safety, pharmacokinetics, and activity of AT-752, a novel nucleotide prodrug with pan-serotype activity against Dengue virus: a phase 2, randomized, double-blind Study","volume":"113","author":"Horga","year":"2025","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2026.119011_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44559-9","article-title":"Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis","volume":"13","author":"Moallemi","year":"2023","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:55:16Z","timestamp":1794563716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":117,"alternative-id":["S0223523426004563"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119011","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dengue virus nonstructural proteins as small-molecule targets: Advances, challenges, and future directions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119011"}}